Global Harmonization of Cancer Trials
An Initiative of
HARMONY is dedicated to achieving greater Global Harmonization of Cancer Trials
Powered by the Mission Advisory Board (MAB) of the Society for Translational Oncology, the MAB acts as a think tank, strategic advisor and collaborator
The Society for Translational Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Challenge
- Too many individuals lack access to clinical trials and the benefits that accrue from them
- This disharmony slows the development and regulatory approval of cancer treatments in all regions
- International Council for Harmonisation (ICH) guidelines exist but have not been uniformly implemented
- We still see differences and inefficiencies
- We need global infrastructure and collaboration so that a drug developed anywhere can be approved everywhere
Our Vision
To drive and facilitate optimal cancer outcomes globally through the improved sharing and exchange of best practices and novel solutions
Our Mission
To expedite the development of novel strategies for cancer prevention and treatment through the harmonization of translational and clinical trial processes by:
- Defining and communicating standards and best practices to streamline cancer trials and maximize equitable participation
- Creating a global forum to drive international collaboration, advocacy, and awareness
- Providing education, support, and advanced solutions for the oncologist community
Strategic Imperatives
Define and communicate standards and best practices to streamline cancer trials and maximize equitable participation
Create a global forum to drive international collaboration, advocacy and awareness
Provide education, support and advanced solutions for the oncologist community
Our Call To Action
The pandemic taught us about the power of collaboration and that we can successfully fight huge medical challenges at speed.
STO gratefully acknowledges support from:
STO welcomes additional support; please contact us for more information.
Resources:
- WHO Guidance for Best Practices for Clinical Trials - Draft
- Clinical Trials Information System: Training and Support | EMA
- Commercial Clinical Trials in the UK: the Lord O’Shaughnessy review - Final Report | GOV.UK (www.gov.uk)
- We Need a Global System for Testing and Approving Cancer Treatments | Harvard Business Review
- Reimagining Patient-Centric Cancer Clinical Trials: A Multi-Stakeholder International Coalition | Nature Medicine
- NCI Center for Global Health - Brief Update (2022)
- Project Orbis: Global Collaborative Review Program | CCR - The Journal of Clinical and Translational Research
- Overview: NCI Center for Global Health (2017)
Organizations of Interest: